in trans

Experiments with irradiated mice show that damage to DNA in the paternal genome is hazardous for the maternally derived genome.

By | February 16, 2001

Irradiation of pre-meiotic stage germ cells was shown to cause germline mutation of mouse minisatellite sequences. In the February 13 Proceedings of the National Academy of Science, Niwa and Kominami report on the effect of irradiation on paternal and maternal minisatellite alleles (Proc Natl Acad Sci USA 2001, 98:1705-1710). They examined length change mutation of the mouse hypervariable minisatellite locus Ms6hm. Male mice were irradiated at the testicular level with 6 gray (Gy) of γ-ray irradiation and crossed with non-irradiated females. The mutant frequency of the paternal allele was 22% for males irradiated at the spermatozoa stage, compared with the 8.4% spontaneous background in non-irradiated parents. Hence, irradiation of post-meiotic germ cells induces minisatellite mutation in F1 mice. In addition, the mutant frequency at the maternally derived allele was also increased in F1 offspring (20% compared with 9.8% in controls) from irradiated fathers. These results imply that radiation-induced genomic instability causes untargeted mutation of paternal alleles in cis and maternal alleles in trans, and caution about the hazard of paternal DNA damage to the maternally derived genome upon radiation exposure.

Popular Now

  1. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  2. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. EPO Revokes Broad’s CRISPR Patent
    The Nutshell EPO Revokes Broad’s CRISPR Patent

    Shortly after ruling out the earliest priority dates on a foundational patent for CRISPR gene-editing technology, the European Patent Office rescinded the patent entirely—and more are likely to follow.

AAAS